AAR PHARMA LTD - Filleted accounts

Registered number
07217901
AAR PHARMA LTD
Filleted Accounts
30 April 2022
AAR PHARMA LTD
Registered number: 07217901
Balance Sheet
as at 30 April 2022
Notes 2022 2021
£ £
Current assets
Debtors 3 1,031 1,022
Creditors: amounts falling due within one year 4 (6,221) (6,211)
Net current liabilities (5,190) (5,189)
Net liabilities (5,190) (5,189)
Capital and reserves
Called up share capital 100 100
Profit and loss account (5,290) (5,289)
Shareholder's funds (5,190) (5,189)
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mr. Ashwini Kumar Shiwach
Director
Approved by the board on 30 January 2023
AAR PHARMA LTD
Notes to the Accounts
for the year ended 30 April 2022
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2 Employees 2022 2021
Number Number
Average number of persons employed by the company 0 0
3 Debtors 2022 2021
£ £
Trade debtors 741 714
Other debtors 290 308
1,031 1,022
4 Creditors: amounts falling due within one year 2022 2021
£ £
Other creditors 6,221 6,211
5 Other information
AAR PHARMA LTD is a private company limited by shares and incorporated in England. Its registered office is:
1st Floor
14 Bowling Green Lane
London
United Kingdom
EC1R 0BD
AAR PHARMA LTD 07217901 false 2021-05-01 2022-04-30 2022-04-30 VT Final Accounts April 2022 Mr. Ashwini Kumar Shiwach No description of principal activity 07217901 2020-05-01 2021-04-30 07217901 core:WithinOneYear 2021-04-30 07217901 core:ShareCapital 2021-04-30 07217901 core:RetainedEarningsAccumulatedLosses 2021-04-30 07217901 2021-05-01 2022-04-30 07217901 bus:PrivateLimitedCompanyLtd 2021-05-01 2022-04-30 07217901 bus:AuditExempt-NoAccountantsReport 2021-05-01 2022-04-30 07217901 bus:Director40 2021-05-01 2022-04-30 07217901 countries:England 2021-05-01 2022-04-30 07217901 bus:FRS102 2021-05-01 2022-04-30 07217901 bus:FullAccounts 2021-05-01 2022-04-30 07217901 2022-04-30 07217901 core:WithinOneYear 2022-04-30 07217901 core:ShareCapital 2022-04-30 07217901 core:RetainedEarningsAccumulatedLosses 2022-04-30 07217901 2021-04-30 iso4217:GBP xbrli:pure